NARO, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 131
NA - Nord America 100
AS - Asia 54
AF - Africa 1
OC - Oceania 1
Totale 287
Nazione #
IT - Italia 103
US - Stati Uniti d'America 98
SG - Singapore 18
HK - Hong Kong 16
IN - India 9
SE - Svezia 9
FI - Finlandia 8
CN - Cina 5
ID - Indonesia 5
BG - Bulgaria 4
DE - Germania 3
CA - Canada 2
PL - Polonia 2
AU - Australia 1
BD - Bangladesh 1
GB - Regno Unito 1
NL - Olanda 1
TG - Togo 1
Totale 287
Città #
Rome 52
Fairfield 17
Singapore 12
Ashburn 10
Woodbridge 9
Seattle 8
Cagliari 6
Wilmington 6
Beijing 5
Florence 5
Helsinki 5
Jakarta 5
San Paolo di Civitate 5
Chandler 4
Sofia 4
Milan 3
New Delhi 3
Princeton 3
Ancona 2
Ann Arbor 2
Boardman 2
Cambridge 2
Cassano delle Murge 2
Houston 2
Lappeenranta 2
Lawrence 2
Millbury 2
Plano 2
Pozzuoli 2
Rimini 2
Stockholm 2
Andover 1
Bologna 1
Boston 1
Canosa di Puglia 1
Falls Church 1
Groningen 1
Halle 1
Lomé 1
Los Angeles 1
Newcastle upon Tyne 1
Parma 1
Pescara 1
San Diego 1
Scarborough 1
Sydney 1
Taranto 1
Toronto 1
Viterbo 1
Warsaw 1
Wroclaw 1
Totale 208
Nome #
Enhancing sensitivity of triple-negative breast cancer to DNA-damaging therapy through chemical inhibition of the m6A methyltransferase METTL3 82
The centrosomal kinase NEK2 is a novel splicing factor kinase involved in cell survival 79
Novel N-(Heterocyclylphenyl)benzensulfonamide Sharing an Unreported Binding Site with T-Cell Factor 4 at the β-Catenin Armadillo Repeats Domain as an Anticancer Agent 56
The RNA-binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinoma 46
Alternative splicing regulation in human cancer 34
Recent advances in drug discovery for Triple-Negative Breast cancer treatment 18
Totale 315
Categoria #
all - tutte 825
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 825


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202031 0 0 0 4 3 4 4 3 5 2 5 1
2020/202115 1 1 0 0 0 0 8 2 3 0 0 0
2021/202230 0 1 3 1 4 0 1 4 2 1 7 6
2022/202333 8 9 1 0 2 3 1 1 3 3 1 1
2023/2024156 13 12 4 3 1 39 17 18 14 18 7 10
2024/202533 6 8 12 7 0 0 0 0 0 0 0 0
Totale 315